.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Dow
Novartis
Baxter
Harvard Business School
Daiichi Sankyo
Citi
Express Scripts
Deloitte

Generated: July 26, 2017

DrugPatentWatch Database Preview

Prednisolone acetate; sulfacetamide sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone acetate; sulfacetamide sodium and what is the scope of prednisolone acetate; sulfacetamide sodium patent protection?

Prednisolone acetate; sulfacetamide sodium
is the generic ingredient in ten branded drugs marketed by Pharmafair, Schering, Allergan, Alcon, Akorn, Bausch And Lomb, and Novartis, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighty-six drug master file entries for prednisolone acetate; sulfacetamide sodium. Two suppliers are listed for this compound.

Summary for Generic Name: prednisolone acetate; sulfacetamide sodium

Tradenames:10
Patents:1
Applicants:7
NDAs:11
Drug Master File Entries: see list86
Suppliers / Packagers: see list2
Clinical Trials: see list3,588
Drug Prices:see low prices
DailyMed Link:prednisolone acetate; sulfacetamide sodium at DailyMed

Pharmacology for Ingredient: prednisolone acetate; sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon
ISOPTO CETAPRED
prednisolone acetate; sulfacetamide sodium
SUSPENSION;OPHTHALMIC087547-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmafair
PREDSULFAIR
prednisolone acetate; sulfacetamide sodium
OINTMENT;OPHTHALMIC088032-001Apr 15, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
METIMYD
prednisolone acetate; sulfacetamide sodium
OINTMENT;OPHTHALMIC010210-002Sep 9, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
METIMYD
prednisolone acetate; sulfacetamide sodium
SUSPENSION/DROPS;OPHTHALMIC010210-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
VASOCIDIN
prednisolone acetate; sulfacetamide sodium
OINTMENT;OPHTHALMIC088791-001Oct 5, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
McKinsey
Teva
Chinese Patent Office
Citi
Healthtrust
Novartis
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot